Skip to Content

A Woman in Nevada Died from an Unstoppable Superbug

Her death is a reminder that antibiotic-resistant bacteria are getting worse, even as they garner little attention.
January 13, 2017

A strain of bacteria resistant to 26 different antibiotics killed a woman in Nevada, a stark warning that humanity continues to lose ground in the fight against antibiotic resistance.

The woman, who was in her 70s and appears to have acquired the infection in India after she broke her leg, died in September, but a report on her case was just published by the Centers for Disease Control and Prevention.

India is known to have more antibiotic-resistant bacteria in the environment than the U.S., in part because poor sanitation and water quality leads people to take hundreds of millions of courses of antibiotics each year for diarrhea. This gives the bugs ample opportunity to develop defenses against the drugs.

But the threat is global. A report issued last year by the U.K. government argued that if measures aren’t taken to stem the rising tide of antibiotic resistance, 10 million people a year could be dying from superbugs by 2050—more than currently die from cancer.

Many doctors say the crisis is already under way. The director of the CDC, Tom Frieden, has called the broad class of superbugs known as CRE (for carbapenem-resistant enterobacteriaceae) “nightmare bacteria.” The bacteria that killed the woman in Nevada was a kind of CRE known as Klebsiella pneumoniae.

STAT spoke with James Johnson, a doctor at the University of Minnesota who studies infectious disease. He offered an even more dire appraisal of the situation. “People have asked me many times, How scared should we be? … How close are we to the edge of the cliff? And I tell them: We’re already falling off the cliff,” he said.

One of the main reasons for this is that developing new antibiotics is not a good way for drug companies to make money. The U.K. government’s report addressed that issue, suggesting that it would be well worth it to spend public funds on paying firms to come up with new compounds to fight superbugs—but the plan has yet to be implemented.

(Read more: STAT, “It’s an Evolutionary Arms Race, and the Superbugs Are Winning”)

Keep Reading

Most Popular

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

open sourcing language models concept
open sourcing language models concept

Meta has built a massive new language AI—and it’s giving it away for free

Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

images created by Google Imagen
images created by Google Imagen

The dark secret behind those cute AI-generated animal images

Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.